From lab to commercialization: Navigate the evolving risks of life science companies -
Life science companies face rapidly evolving risks—from navigating insurance needs during early funding stages to understanding...more
6/5/2025
/ Artificial Intelligence ,
Biotechnology ,
C-Suite Executives ,
Clinical Laboratories ,
Clinical Trials ,
Commercial Insurance Policies ,
Cyber Insurance ,
Early Stage Companies ,
Emerging Growth Companies ,
Initial Public Offering (IPO) ,
Insurance Industry ,
Life Sciences ,
Research and Development ,
Risk Management ,
Risk Mitigation ,
Webinars
Are the rewards of using artificial intelligence (AI) in the healthcare industry worth the inherent risks?
Whether you find yourself on one side of this issue or on the fence, we encourage you to listen to our recent...more